The BioPharm Brief: Obesity Data and Manufacturing Shape Drug Progress

Oct 05, 08:30 PM
Headliner
Share
Subscribe

Welcome to The BioPharm Brief, your daily snapshot of the latest developments shaping biopharmaceutical research, clinical progress, and regulatory strategy. Today’s update focuses on new obesity data, expanded biosimilar manufacturing capacity, a manufacturing-related FDA review delay, and longer-term results for a potential cutaneous lupus treatment.

Share
Subscribe
Next
The BioPharm Brief: Room Temperature, RNA, and ADCs
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: Cancer, Personalized
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief